The clot-dissolving medication, alteplase, improved stroke patients’ recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary late-breaking science presented today at the American Stroke Association’s International Stroke Conference 2025.
Rona Therapeutics secures funds for siRNA pipeline expansion
The company will use the investment proceeds to develop next-generation RNA platforms. Credit: FOTOGRIN / Shutterstock. Rona Therapeutics has secured $35m in its Series A+